6 Analysts Assess FMC: What You Need To Know
Analysts' ratings for FMC (NYSE:FMC) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 3 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 2 | 2 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $49.33, with a high estimate of $61.00 and a low estimate of $44.00. Observing a 10.43% increase, the current average has risen from the previous average price target of $44.67.
Exploring Analyst Ratings: An In-Depth Overview
An in-depth analysis of recent analyst actions unveils how financial experts perceive FMC. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Joshua Spector | UBS | Lowers | Neutral | $44.00 | $45.00 |
| Aleksey Yefremov | Keybanc | Raises | Overweight | $61.00 | $53.00 |
| Arun Viswanathan | RBC Capital | Raises | Sector Perform | $47.00 | $40.00 |
| Joshua Spector | UBS | Raises | Neutral | $45.00 | $41.00 |
| Benjamin Theurer | Barclays | Raises | Overweight | $49.00 | $48.00 |
| Richard Garchitorena | Wells Fargo | Raises | Overweight | $50.00 | $41.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to FMC. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for FMC's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of FMC's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on FMC analyst ratings.
Delving into FMC's Background
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Understanding the Numbers: FMC's Finances
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Decline in Revenue: Over the 3M period, FMC faced challenges, resulting in a decline of approximately -13.79% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.96%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): FMC's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.35% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): FMC's ROA stands out, surpassing industry averages. With an impressive ROA of -0.13%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: FMC's debt-to-equity ratio surpasses industry norms, standing at 0.91. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
How Are Analyst Ratings Determined?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.